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ABSTRACT
Zinc-finger proteins (ZFPs) have long been recog-
nized for their potential to manipulate genetic infor-
mation because they can be engineered to bind
novel DNA targets. Individual zinc-finger domains
(ZFDs) bind specific DNA triplet sequences; their
apparent modularity has led some groups to pro-
pose methods that allow virtually any desired DNA
motif to be targeted in vitro. In practice, however,
ZFPs engineered using this ‘modular assembly’
approach do not always function well in vivo.
Here we report a modular assembly scoring strategy
that both identifies combinations of modules least
likely to function efficiently in vivo and provides
accurate estimates of their relative binding aff-
inities in vitro. Predicted binding affinities for 53
‘three-finger’ ZFPs, computed based on energy con-
tributions of the constituent modules, were highly
correlated (r=0.80) with activity levels measured
in bacterial two-hybrid assays. Moreover, Kd
values for seven modularly assembled ZFPs and
their intended targets, measured using fluorescence
anisotropy, were also highly correlated with predic-
tions (r=0.91). We propose that success rates
for ZFP modular assembly can be significantly
improved by exploiting the score-based strategy
described here.
INTRODUCTION
The ability to reliably engineer DNA binding proteins that
recognize any desired DNA sequence would provide an
unprecedented level of control over genetic information;
for example, by allowing the creation of site-speciﬁc
nucleases that speciﬁcally alter genomic DNA (1–5). The
C2H2 zinc-ﬁnger domain (ZFD) is arguably the best char-
acterized DNA binding motif and oﬀers considerable pro-
mise for the rational engineering of site-speciﬁc DNA
binding proteins (6–11). Zinc-ﬁnger proteins (ZFPs) con-
sist of multiple individual ZFDs, each of which typically
recognizes adjacent sequence triplets in duplex DNA
(Figure 1). An individual ZFD comprises a pair of anti-
parallel b-strands and one a-helix, which coordinate a zinc
ion through conserved pairs of cysteine and histidine resi-
dues. In the canonical three-ﬁnger domain of the Zif268
transcription factor, the amino acid side chains at posi-
tions  1, +3 and +6 relative to the amino-terminal end
of the a-helix typically make base-speciﬁc contacts with
three adjacent nucleotides within the major groove of
double-stranded DNA (12). An aspartic acid residue in
the +2 position of the DNA recognition helix can specify
a fourth nucleotide, resulting in either target-site overlap
with an adjacent module or speciﬁcation of an additional
nucleotide at the 30-end of the target site (13,14).
Several research groups have characterized ZFDs that
recognize many of the 64 possible DNA triplets (15–20).
Using a ‘modular assembly’ approach, novel ZFPs that
recognize variant DNA sites are assembled by simply
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ZFPs made by modular assembly display a wide range of
binding aﬃnities and speciﬁcities (15,19,21–23). Although
modular assembly has proven useful for some in vivo
applications, such as artiﬁcial transcription factors,
recent work suggests that the success rate of creating arti-
ﬁcial zinc-ﬁnger nucleases (ZFNs–fusions of engineered
zinc ﬁngers to a non-speciﬁc nuclease domain) by this
method is considerably lower (24,25). These low success
rates, together with the inability to predict which ZFPs
are likely to function in vivo, have motivated our groups
to improve the procedures and design criteria for ZFP
engineering (25,26).
The present study was motivated by our observation
that among a small set of modularly assembled ZFPs,
those that fail to function in vivo are more likely to possess
modules previously shown to have relatively low aﬃnity
for target DNA. This observation implies that insuﬃcient
aﬃnity can contribute to poor function in vivo and also
suggested that it might be possible to predict the aﬃnity
of a modularly assembled ZFP using existing aﬃnity data
for component modules. Here we test these hypotheses
and demonstrate that both the in vitro binding aﬃnity
and the lack of in vivo activity of a ZFP can be predicted
using the energy contributions of its component ZFDs.
Our approach for predicting the binding of ZFPs to
desired target sequences should improve success rates of
modular assembly by guiding investigators away from
target sites and ZFP combinations least likely to function
in vivo.
MATERIALS AND METHODS
Zinc-finger modules and three-finger arrays (ZFPs)
All ZFDs used in these experiments have been described
by the Barbas group (15) and are referred to as ‘Barbas
modules’. ZFPs containing desired three-ﬁnger (three-
module) arrays were assembled by iterative ligation and
cloning of restriction fragments encoding ZFDs using
reagents and protocols previously described by the Zinc
Finger Consortium (http://www.zincﬁngers.org/) (27).
ZFP-encoding fragments were then cloned into vectors
for expression as Gal11P-hybrid proteins in the bacterial
two-hybrid (B2H) system as previously described (27).
B2Hassays
A series of B2H reporter plasmids, each harboring a target
binding site for one of 27 diﬀerent three-ﬁnger ZFPs, was
constructed by cloning synthetic target oligonucleotides
into reporter plasmid pBAC-lacZ as previously described
(27). Binding of a Gal11P-ZFP hybrid protein to the
target sequence on a B2H reporter plasmid triggers tran-
scriptional activation of a lacZ reporter gene encoding
b-galactosidase. In vivo ZFP performance was therefore
assayed using a b-galactosidase assay in which ZFP-
induced activation of lacZ expression was measured rela-
tive to control constructs lacking the ZFP.
Zincfinger–maltose binding proteinfusion protein
construction, expression and purification
Zinc ﬁnger–maltose binding protein (MBP) fusion protein
constructs were generated by transferring three-ﬁnger
arrays, assembled as described above, into pHMTC (28).
The MBP fusion plasmids were transformed into BL21
Escherichia coli cells (Invitrogen) using standard chemical
transformation procedures (29).
For protein expression, 5ml cultures were grown for
16h at 308C with agitation in ZFE broth [Luria Broth
(LB), 1.11mM dextrose, 100mg/ml ampicillin]. Expansion
cultures of 10ml were inoculated from these overnight
cultures (1:100 dilution) and grown to an OD600 of 0.5
before a 2h induction with isopropyl b-D-1-thiogalacto-
pyranoside (IPTG). Cells were harvested by centrifugation
for 10min at 4000g at 48C and frozen overnight at  208C.
The following day, cells were resuspended in 4ml WB1
(15mM HEPES pH 7.8, 200mM NaCl, 20mM ZnSO4)/
1mM PMSF/0.1% Nonidet
TM P40 (NP-40) and refrozen
at  708C. Cells were then thawed in ice water and centri-
fuged at 9000g at 48C for 20min. To remove remaining
nucleic acids, the resulting supernatant was transferred
to a new cold tube and polyethyleneimine was added to
0.1%. The supernatant was then incubated for 30min
before a second centrifugation at 16000g at 48C for
30min.
Amylose beads (NEB) were prepared in 50ml aliquots in
1.5ml micro-centrifuge tubes according to manufacturer’s
instructions. Beads were washed (suspended, spun down
and supernatant removed) three times in 1ml WB1/0.1%
NP-40at 48C and resuspended in 450ml WB1. For aﬃnity
puriﬁcation, 1ml of clariﬁed protein supernatant was
added to prepared beads, and incubated at 48C for
30min. The slurry was centrifuged and the supernatant
was removed. The proteins bound to beads were washed
two times with 700ml WB1/0.1% NP-40 and two times
with zinc buﬀer A (ZBA; 10mM Tris–HCl, pH 7.5,
90mM KCl, 1mM MgCl2,9 0 mM ZnCl2)/0.1% NP-40
(15). Puriﬁed proteins were then eluted in 200ml ZBA/
0.1% NP-40/40mM maltose for 30min at room tempera-
ture, with gentle agitation. After elution, beads were cen-
trifuged at 16000g. The supernatant was transferred to a
new cold tube and centrifuged again at 16000g. The super-
natant was transferred to a new cold tube and gently stir-
red to mix protein. Proteins were stored at  708Ci n
Axygen MaxymumRecovery
TM tubes. Protein concentra-
tions were estimated using a Bradford assay against a
Figure 1. A three-ﬁnger ZFP with its DNA target site. A ZFP consist-
ing of three adjacent ZFDs binds its target DNA through contacts
between the amino acids of the DNA recognition helices and consecu-
tive nucleotides in the DNA. The protein chain is drawn in the N- to
C-terminal direction and the DNA target in the 30–50 direction. Note
that an ‘unnatural’ extended array is shown to better illustrate the
critical amino acid/nucleotide contacts. Structure diagrams were gener-
ated using PyMol (http://www.pymol.org).
Nucleic Acids Research,2009, Vol. 37,No. 2 507bovine serum albumin (BSA) standard in ZBA/0.1%
NP-40.
Binding measurements using fluorescence anisotropy
Binding reactions were performed in ZBA/0.1% NP-40/
0.1mg/ml non-acetylated BSA (Sigma) for 30min on ice
with 5 nM target DNA. Target sites (shown in Figure 2a)
were formed using hairpin DNA oligonucleotides as
described (15). HPLC puriﬁed, 30-6-FAM-labeled oligonu-
cleotides were ordered from Integrated DNA
Technologies (Coralville, IA, USA). In each experiment,
two serial dilutions of puriﬁed ZFP-MBP fusion protein
were performed over a range of 1000–0.122 nM. Reported
binding aﬃnity values are based on the average of three
separate binding experiments, performed on diﬀerent
days, using three separate protein preparations. Fluo-
rescence anisotropy (FA) measurements were made
using a Varian Cary Eclipse spectrophotometer in
L-format conﬁguration. Each value was based on ﬁve
measurements averaged over 5s, using a 490nm excitation
wavelength (5nm slit width), and 530nm emission wave-
length (20nm slit width) at 880V. Background light scat-
tering for each protein sample dilution was measured and
subtracted to correct for protein concentration-dependent
variation in intensities. Kd values were determined by non-
linear regression (30,31) using Prism (http://www.graph
pad.com/prism/Prism.htm).
RESULTS
To test the hypothesis that binding energy contributions
of individual ZFDs can be used to predict the in vitro
binding aﬃnities and in vivo performance of extended
ZFP arrays, 27 three-module ZFPs were constructed by
assembling various GNN-speciﬁc modules previously
characterized by the Barbas group (15). ZFP compositions
were chosen to systematically explore a wide range of
predicted binding aﬃnities and to test the inﬂuence of
context on module performance. As shown in Table 1,
ZFDs were divided into three aﬃnity classes based on
their reported aﬃnity constants measured in a ﬁxed con-
text, namely as ﬁngers in the middle position of a three-
ﬁnger Zif268 variant (15). Modules comprising Zif268
variants with Kd values <10 nM were categorized as
‘strong’, Kd=10–30 nM as ‘moderate’ and Kd>30 nM
as ‘weak’ (Table 1). Using three diﬀerent modules to
represent each binding class, all possible combinations of
strong, moderate and weak aﬃnity modules for a three-
module ZFP were assembled. To allow direct comparisons
among proteins that diﬀer by a single module, ZFPs were
designed in subgroups in which only one ﬁnger position
was varied (Table 2).
Predicting relative binding energiesformodularly
designedZFPs
If one assumes that the binding energy of a three-ﬁnger
ZFP (G8ZFP) is equal to the sum of the binding energies
of its three component ZFDs (G8ZFD) [Equation (1)], it
follows that the diﬀerence in binding energy between any
two ZFPs is the sum over the positions of the diﬀerence in
binding energy between the modules at each position
[Equation (2)].
G 
ZFP ¼ G 
ZFD1 þ G 
ZFD2 þ G 
ZFD3 1
GZFP1 ZFP2 ¼ G 
ZFP1 F1   G 
ZFP2 F1

þ G 
ZFP1 F2   G 
ZFP2 F2

þ G 
ZFP1 F3   G 
ZFP2 F3

2
Because the ZFDs used in this study were evaluated
in the middle (F2) position of a three-ﬁnger ZFP, and
because the other ﬁngers (F1 and F3) were constant in
all these ZFPs, the diﬀerences in measured binding con-
stants among these constructs should be attributable to
the diﬀerences in binding energy between the F2 ZFDs.
Thus, G can be calculated between any two ZFDs
by using the identity relating Gibbs free energy to Kd
[Equation (3), RT=0.58].
G 
ZFD1   G 
ZFD2 ¼  RTln KdZFP1=KdZFP2 ðÞ 3
To compare binding aﬃnity measurements with pre-
dicted values, the predicted G was calculated as the
diﬀerence between each ZFP and a standard (STD) ZFP
composed entirely of the F2 domain of parental C7 (15).
GZFD1 ¼  RT ln KdZFP1=KdSTD ðÞ ð
þln KdZFP2=KdSTD ðÞ
þ ln KdZFP3=KdSTD ðÞ Þ
4
Thus, using Equation (4) and binding constants for ZFP
variants published by the Barbas group (15), we predicted
G values for 27 novel modularly assembled ZFPs con-
structed using Barbas GNN modules (Figure 2). Predicted
G values ranged from 2.1kcal/mol for ZFP #1, con-
taining three strong modules to 8.2kcal/mol for ZFP #27
containing three weak modules.
InvivoactivitiesofZFPsarehighlycorrelated withpredicted
binding energies
To evaluate in vivo binding of the 27 modularly assembled
ZFPs to their cognate DNA targets, we used a quantita-
tive B2H assay (32). In this assay, binding of a ZFP to its
target site activates transcription of a lacZ reporter posi-
tioned downstream of an adjacent promoter. Thus, ZFP
DNA-binding activity can be assessed by quantifying
b-galactosidase activity in ZFP-expressing cells relative
to control cells that do not express the ZFP. We chose
to use the B2H system as an assay because recently pub-
lished studies have shown that absence of ZFP activity in
this system is an excellent predictor for failure of these
proteins to function as ZFNs in human cells (24–26).
For 25 of the 27 ZFPs tested, the level of lacZ activation
observed was in excellent agreement with predicted ener-
gies (Figure 2a). Expression of the two ZFPs with the
strongest predicted binding energy was toxic to cells,
508 Nucleic Acids Research, 2009, Vol. 37, No. 2Figure 2. Predicted binding energies are highly correlated with in vivo activity in a B2H assay. Twenty-seven three-module ZFPs were designed by
modular assembly to span a broad range of predicted binding aﬃnities. (a) DNA recognition helix sequences, DNA sequence targets, predicted
energies, measured fold-activation in the B2H assay, and standard error of the mean are listed for each construct. Entries are sorted from lowest to
highest predicted G. Constructs marked with an asterisk were also tested in vitro (Figure 4). (b) ZFP activities in the B2H assay are plotted versus
predicted energies. The two constructs with highest predicted aﬃnities were toxic to their host cells and therefore could not be included. Points shown
as red diamonds correspond to proteins containing the GTA-speciﬁc QSSSLVR module (see text). Best-ﬁt lines from a segmental linear regression
model using all points (dashed line, r=0.77), or excluding red points (solid line, r=0.86) are shown. (c) Same as (b), except that values indicated by
red triangles were adjusted assuming a binding aﬃnity of 2.5nM, rather than 25nM, for the GTA-speciﬁc QSSSLVR module; this increases the
correlation coeﬃcient to 0.86 (see text for details).
Nucleic Acids Research,2009, Vol. 37,No. 2 509preventing analysis of these constructs. Several models
describing the relationship between predicted and mea-
sured activity were evaluated, with segmental linear
regression providing the best ﬁt (r=0.77; Figure 2b,
dashed line). Inspection of the data revealed that the
GTA-speciﬁc module (QSSSLVR) was present in most
ZFPs that exhibited signiﬁcantly greater activation than
predicted (Figure 2b, red diamonds). Excluding ZFPs con-
taining this module from the analysis increased the corre-
lation coeﬃcient to 0.86 (Figure 2b, solid line).
The predictions described above relied on published
in vitro binding aﬃnities for ZFPs in which modules
were evaluated in a ﬁxed context (15) to estimate bind-
ing contributions of individual modules. In an alternate
approach, we predicted ZFP performance by solving indi-
vidual module contributions as component variables of
a system of linear equations. Brieﬂy, in constructing the
27 diﬀerent three-ﬁnger proteins, nine ZFDs were used
approximately 8–10 times (approximately three times at
each of the possible three positions, Table 1). Assuming
that the energy contributions of individual ZFDs in a ZFP
are additive, the B2H activity of each ZFP was considered
to result from its particular combination of modules
(Supplementary Figure 1). Individual module contribu-
tions were calculated for each ZFP using a leave-one-out
linear system solution. Expected lacZ activation in the
B2H assay for each of the ZFPs was then predicted by
summing individual module contributions. As shown in
Figure 3, expected levels of activation computed in this
manner were highly correlated with actual B2H activity
measurements (r=0.86).
The energy contributions computed using a system
of linear equations to analyze in vivo activity data from
the B2H assay indicate that the GTA-speciﬁc QSSSLVR
module binds with higher aﬃnity than previous Kd esti-
mates. This is consistent with our conclusion based on
inspection of energies computed from in vitro binding con-
stants (Figure 2b). We estimated a new value for this
module by calculating the Kd that optimizes the correla-
tion of predicted energies with the B2H data. This
approach resulted in an estimated Kd of 2.5 nM for this
module, 10-fold lower than the previously reported value
of 25 nM (15). Incorporating this new estimate improved
correlation between the in vitro energy model and in vivo
fold activation data (r=0.86, Figure 2c).
To directly evaluate the eﬀects of individual module
aﬃnities on in vivo performance, sets of related ZFPs
designed to vary at a single module position were analyzed
for diﬀerences in B2H activity (Table 2). For all three sets
of ZFPs in which the F1 position was varied (while F2 and
F3 were ﬁxed), the greatest in vivo activity was observed
when the F1 position contained a high aﬃnity module; the
least activity was observed with a low aﬃnity module in
this position. The same trend was observed for all four
Table 2. Single module substitutions in ZFPs alter target aﬃnity
Position
Varied
ZFP
No.
F1
Helix
F2
Helix
F3
Helix
Fold
Activation
1 7 RSDNLVR DPGHLVR TSGNLVR 3.11
16 QSSSLVR DPGHLVR TSGNLVR 1.88
25 TSGELVR DPGHLVR TSGNLVR 1.54
8 RSDNLVR DPGALVR TSGHLVR 2.59
17 QSSSLVR DPGALVR TSGHLVR 1.69
26 TSGELVR DPGALVR TSGHLVR 1.59
9 RSDNLVR TSGELVR DPGALVR 2.47
18 QSSSLVR TSGELVR DPGALVR 1.85
27 TSGELVR TSGELVR DPGALVR 1.71
2 10 RSDELVR TSGSLVR TSGSLVR 1.77
13 RSDELVR QSSSLVR TSGSLVR 2.19
11 RSDELVR TSGSLVR RSDELVR 1.89
14 RSDELVR QSSSLVR RSDELVR 2.81
12 TSGHLVR TSGSLVR TSGELVR 1.43
15 TSGHLVR QSSSLVR TSGELVR 1.96
3 1 TSGSLVR RSDNLVR RSDNLVR Toxic
2 TSGSLVR RSDNLVR QSSSLVR 4.88
3 TSGSLVR RSDNLVR DPGHLVR 3.51
4 TSGNLVR TSGHLVR RSDNLVR Toxic
5 TSGNLVR TSGHLVR RSDELVR 1.71
6 TSGNLVR TSGHLVR DPGHLVR 1.41
19 DPGHLVR TSGNLVR RSDNLVR 3.58
20 DPGHLVR TSGNLVR QSSSLVR 3.09
21 DPGHLVR TSGNLVR TSGELVR 0.92
22 DPGALVR RSDELVR TSGSLVR 1.95
23 DPGALVR RSDELVR QSSSLVR 1.69
24 DPGALVR RSDELVR TSGELVR 1.23
Individual ZFDs, represented by their DNA recognition helix, are
shaded to indicate their aﬃnity class (Strong, Moderate, Weak, see
Table 1). For each subgroup (demarcated by horizontal lines), modules
in two positions were held constant while the position indicated in the
leftmost column was varied. Fold activation denotes performance of
the ZFP in the B2H assay. Toxic refers to the poor growth of E. coli
cultures observed when cells expressed certain ZFPs.
Table 1. ZFP variants that diﬀer in the middle (F2) position bind
targets with variable aﬃnities
Helix
N- to -C
Target
50–30
Aﬃnity
(Kd, nM)
Strong QSSNLVR GAA 0.5
RSDHLTT TGG 0.5
RSDNLVR GAG 1
QSGDLRR GCA 2
TSGNLVR GAT 3
DPGNLVR GAC 3
QRAHLER GGA 3
TSGSLVR GTT 5
RSDKLTR GGG 6
RSDDLVR GCG 9
Moderate TSGHLVR GGT 15
RSDELVR GTG 15
QSSSLVR GTA 25
Weak DPGHLVR GGC 40
DPGALVR GTC 40
TSGELVR GCT 65
DCRDLAR GCC 80
The data in this table were reported by Segal et al. (15). Each ZFD in
the F2 position was selected to bind a particular target triplet. The F1
and F3 modules (derived from Zif268) were the same in each construct.
A binding aﬃnity constant for each ZFP variant was determined using
an EMSA. Here, modules are classiﬁed based on the aﬃnity of the
ZFPs for their cognate target sites (Strong, Moderate, Weak). Three
modules from each class were chosen to construct 27 diverse three-
module ZFPs (Table 2).
510 Nucleic Acids Research, 2009, Vol. 37, No. 2groups in which the F3 position was varied while the F1
and F2 ﬁngers were ﬁxed. For sets in which the F2 posi-
tion was varied, only one strong module (TSGSLVR) and
one moderate aﬃnity module (QSSSLVR) were tested.
In these cases, the moderate aﬃnity module outperformed
the high aﬃnity module. These results suggest that the
eﬀect of single module substitutions on relative binding
aﬃnity can be predicted reliably in most cases.
In summary, three lines of analysis: (i) predictions based
on in vitro binding constants for modules in a ﬁxed con-
text, (ii) predictions derived from a system of linear equa-
tions based on in vivo performance and (iii) analysis of the
eﬀects of various single ﬁnger substitutions in vivo, demon-
strate that in vivo performance for ZFPs can be predicted
based on DNA-binding aﬃnities of individual ZFDs.
In vitroDNA binding affinities ofZFPsare highlycorrelated
withpredicted bindingenergies
Our success in estimating the activities of ZFPs in the B2H
assay suggested that our scoring scheme could be applied
more generally to predict in vitro ZFP aﬃnities. To test
whether activation measured in the B2H assay directly
reﬂects DNA binding aﬃnity for the desired target site,
9 of the 27 engineered proteins, along with a control
Zif268 protein, were chosen for in vitro binding aﬃnity
measurements (Figure 4). Kd values were determined
using ﬂuorescence anisotropy (FA), a rapid and reprodu-
cible solution-based DNA binding assay that allows com-
putation of the bound fraction of a ﬂuorescently labeled
ligand, based on the decrease in its rotational velocity due
to binding (33,34).
As shown in Figure 5, binding aﬃnity constants deter-
mined by FA were highly correlated with predicted ener-
gies. The two ZF proteins with highest predicted aﬃnities
were toxic to bacterial cells, prohibiting puriﬁcation of
suﬃcient quantities of protein for in vitro analysis.
Energies computed based on previously published
in vitro aﬃnity measurements for modules in a ﬁxed con-
text (15) were proportional to the log of Kd’s measured in
our experiments (r=0.91) (Figure 5a). As before, assum-
ing a Kd of 2.5 nM for the QSSSLVR module signiﬁcantly
improved the correlation (r=0.97). Predicted in vivo acti-
vation levels generated by the leave-one-out linear system
method were also highly correlated with experimentally
determined binding constants (r=0.93; Figure 5b).
Thus, results obtained using a rapid and reliable spectro-
scopic method suggest that ZFP binding aﬃnities mea-
sured in vitro generally correspond to results obtained
in vivo using the B2H system. This demonstrates that
our rule-based strategy can be used to predict ZFP
DNA binding aﬃnity.
Abinding energy threshold forZFP function in vivo
To evaluate the generality of this rule-based approach, we
calculated predicted energies for another set of modularly
assembled ZFPs that had been previously evaluated using
the B2H system (25). From 168 modularly assembled
ZFPs, we selected all ZFPs comprising GNN or TGG
modules for which published in vitro DNA binding aﬃnity
constants are available [measured in the F2 position of
the standard Zif268 variant backbone (15)]. As shown in
Figure 6a, based on a segmental linear regression model,
binding energies for 24 of these 26 ZFPs are highly corre-
lated (r=0.80) with reported B2H activity measurements.
These results are also in excellent agreement with the
results described above and shown in Figure 2b, although
slightly higher activation levels were uniformly observed
in the latter experiments. Notably, both sets of experi-
ments identify a G of  5kcal/mol (corresponding to
a Kd of  100 nM) as the threshold for zinc-ﬁnger function
in vivo (in bacterial cells). We also used the scoring func-
tion generated from the B2H experiments performed by us
(and shown in Figure 2c) to predict B2H activity for the
24 ZFPs evaluated by Ramirez et al. (25). Again, the pre-
dicted and measured fold-activation scores were in
close agreement, with a correlation coeﬃcient of 0.79
(Figure 6b). Taken together, these results suggest that
the scoring function developed and evaluated may be gen-
erally applicable to ZFPs assembled using the Barbas lab
GNN modules.
DISCUSSION
Using a rule-based strategy that combines experimentally
determined binding energies of individual ZFDs, we were
able to compute binding energies for ZFPs made from
a particular set of well-characterized GNN modules (15).
We also showed that these predicted binding energies are
in excellent agreement (r=0.91; Figure 5a) with binding
aﬃnity constants measured directly in vitro. Furthermore,
we showed a strong correlation between these computed
Figure 3. ZFDs contribute additively to B2H activity, independent of
context and position. For each ZF protein, the expected contribution to
B2H activity from each of its component modules was estimated by
solving a system of linear equations representing the other 24 proteins
(see text). Comparison of actual versus predicted B2H activity
(expressed as relative fold-activation in the B2H assay) reveals a high
correlation (r=0.86).
Nucleic Acids Research,2009, Vol. 37,No. 2 511binding energies and ZFP activities in a B2H system for
two diﬀerent sets of modularly assembled three-ﬁnger
ZFPs. This is an important advance because a ZFP that
lacks activity in the B2H system will also have a high
Figure 6. Predicted ZFP performance agrees with in vivo activity for an
independently generated set of ZFPs. Data shown are for 24 of 26 ZFPs
containing characterized GNN or TGG modules, constructed and eval-
uated by Ramirez et al. (25) (a) A segmental linear regression model
provides an excellent ﬁt of in vivo ZF-induced fold activation measured
in the B2H assay with predicted binding energies (r=0.80). (b) ZF-
induced fold activation values measured in the B2H assay for 24 ZFPs
from Ramirez et al. (25) are also highly correlated (r=0.79) with pre-
dicted fold-activation levels calculated based on a scoring function
derived from the segmental linear regression model ﬁt for the 25 ZFPs
shown in Figure 2a (see text for details). Note: predictions for 2 of 26
ZFPs containing characterized GNN or TGG modules from Ramirez
et al. (25) were considered outliers (values were outside the range included
in these graphs); they were not included in the regression analysis.
Figure 4. Determining binding aﬃnity constants using ﬂuorescence anisotropy. (a) A representative in vitro binding isotherm obtained using FA.
Data points for each ZFP were collected using three separate puriﬁed protein preparations, each assayed for binding activity on a diﬀerent day.
Curve ﬁtting was performed using Prism. (b) Kd values for seven modularly assembled ZFPs, determined in FA experiments. Note that two ZFPs
were toxic to host cells, preventing puriﬁcation of proteins in quantities required for in vitro analysis.
Figure 5. In vitro aﬃnity constants for ZFPs are highly correlated with
predictions. Using aﬃnity constants for seven ZFPs determined by FA
(Figure 4b), log(Kd) is plotted against: (a) predicted energy, expressed
as G in kcal/mol (r=0.91) and (b) predicted B2H activity based on
a leave-one-out system of linear equations analysis (r=0.93).
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cells (24–26). Thus, using only our scoring method,
researchers can now identify target sites that will have
a high probability of failing to yield functional zinc-
ﬁnger arrays by the method of modular assembly. Our
rule-based strategy will thus allow researchers to focus
their modular assembly eﬀorts on a smaller number of
target sites with a higher probability of success.
We believe that our results also provide one potential
explanation for the discrepancy between the overwhelm-
ing success rates for a previous in vitro report (35) and the
low in vivo success rates observed for ZFPs in the recent
study of Ramirez et al. (25): many of the modules used
to perform modular assembly likely possess low
aﬃnities. Our data suggest, in fact, that 30–50% of poten-
tial three-ﬁnger ZFPs made wholly from the Barbas GNN
modules will fail to function in the B2H system, a result
in agreement with the recently published results of
Ramirez et al. (25).
Although our results demonstrate that the energy con-
tributions of individual ZFDs in a ZFP array are additive,
we also believe they lend additional support to the notion
that context is an important parameter that should be
accounted for when engineering multi-ﬁnger ZFPs (i.e.
that one single ZFD module will not always be optimal
or adequate for recognition of its cognate 3-bp subsite
in diﬀerent multi-ﬁnger ZFP contexts). For example, our
data show that although a weak ﬁnger will sometimes be
found in a nonfunctional ZFP array (if it is joined together
with other weak aﬃnity ZFDs), it will also sometimes be
found in functional arrays when paired with stronger aﬃ-
nity ZFDs. In addition, our data show that although
strong ﬁngers will sometimes be found in functional
ZFPs, they can be found in nonfunctional ZFPs.
Furthermore, the use of three strong ﬁngers in a ZFP
can lead to toxicity in E. coli cells. Although the precise
mechanism of this toxicity is unclear, a reasonable hypoth-
esis is that excessively high aﬃnity leads to binding to
related but oﬀ-target sequences with suﬃcient aﬃnity to
cause biological consequences (essentially, excessive aﬃ-
nity leading to problems of speciﬁcity). Thus, our data
further re-enforce the ideas that individual ZFDs do not
function completely independently and that the speciﬁc
attributes of neighboring ﬁngers do matter in the context
of engineering a multi-ﬁnger ZFP.
The importance of context-dependent eﬀects also sug-
gests that identiﬁcation of additional ZFDs with variable
aﬃnities for GNN triplets may be needed if the eﬃciency
of modular assembly is to be improved. If such ZFDs were
available, it might be possible to achieve higher success
rates for modular assembly by creating several ZFPs
for a given target site so as to identify a combination
that balances aﬃnities (and presumably, speciﬁcities) of
its component ZFDs. A related point is that our ﬁndings
also suggest one possible reason why more complex selec-
tion-based methods that account for context-dependent
eﬀects [e.g. the OPEN method recently described by
Joung and colleagues (26,32)] may be more successful
than modular assembly: these methods are able to balance
the overall aﬃnity and speciﬁcity of the ﬁnal ZFP array by
identifying optimal combinations from various ZFDs with
a range of aﬃnities and speciﬁcities for their target 3-bp
subsites.
The strong correlations among predicted binding ener-
gies, in vivo activities, and in vitro binding aﬃnity con-
stants for the ZFPs analyzed in this work suggests that
our rule-based approach might be extended to evaluate
arrays assembled using GNN modules from other sources
(17,19) and non-GNN modules. We have not yet evalu-
ated such modules, but our work demonstrates two ways
this could be achieved: (i) by directly measuring in vitro
binding constants for modules in the F2 position of a
standardized ZFP framework and (ii) by computing indi-
vidual module contributions to ZFP binding as compo-
nent variables of a system of linear equations that describe
their activities (measured in vivo in this work, but in vitro
binding constants could also be used). The energy
scoring scheme proposed here will allow researchers to
determine whether a modular assembly strategy is likely
to be feasible for speciﬁc targets of interest, based on cur-
rently available well-characterized modules, or whether an
alternative selection-based engineering strategy should be
considered.
A recent study on the use of ZFNs for homologous
recombination cited lack of speciﬁcity as a primary deter-
minant of ZFN-mediated toxicity in human cells (24).
A likely mechanism for ZFN-induced toxicity is through
binding to genomic sequences similar to the desired target
sequence. As noted above, we observed toxicity in bacter-
ial cells for several ZFPs, even in the absence of a fused
nuclease domain, suggesting that ZFP binding to certain
sites in genomic DNA can be toxic, particularly for high
aﬃnity ZFPs. Although this is the ﬁrst published report
of such toxicity in bacterial cells that we are aware of, it
has been observed previously for several other sites
(Joung,J.K. unpublished data). However, bacterial expres-
sion of ZFPs with aﬃnities in the pM range, with no toxic
eﬀects, has also been reported (19,36,37). High-through-
put chip or microﬂuidics-based DNA binding experiments
(38–41) could be used to obtain aﬃnity and speciﬁcity
data for virtually every possible target site for a given
ZFP, providing additional insight into ZFP-induced toxi-
city and into the fundamental rules that govern the aﬃnity
and speciﬁcity of DNA recognition by zinc-ﬁnger DNA
binding proteins.
A correlation between ZFP binding constants measured
in vitro and functional activity measured in vivo has
also been observed by others using diﬀerent reporter sys-
tems (37). A similar degree of correlation was observed
using the B2H system in our study (Supplementary
Figure 2). Our results further demonstrate that measur-
able ZFP activity in an in vitro binding assay does not
necessarily translate into adequate function in vivo,i n
agreement with Beerli et al. (42). However, the energy
threshold we determined for ZFP activity in vivo, using
B2H assays, corresponds to a Kd of  100 nM, and thus
diﬀers from the estimated threshold Kd of  10nM
reported as the minimum aﬃnity necessary for ZFP func-
tion in mammalian cells (42). The signiﬁcance of this dif-
ference between thresholds determined in bacterial and
mammalian cells is diﬃcult to evaluate, given that func-
tional assays and Kd measurements were performed in
Nucleic Acids Research,2009, Vol. 37,No. 2 513diﬀerent laboratories using diﬀerent assays and with ZFPs
containing diﬀerent numbers of ﬁngers.
Stormo and colleagues (43–47) have shown that the
DNA-binding speciﬁcity of ZFPs can be eﬀectively pre-
dicted from additive energy contributions of individual
residues that make base-speciﬁc contacts with target
site nucleotides. Our results complement this idea by
demonstrating that the aﬃnity of ZFPs also can be pre-
dicted, using aﬃnity data for component modules. Our
application of the binding energy additivity concept diﬀers
somewhat from that used by Stormo to predict speciﬁcity
in that it assumes additivity of energy contributions at the
individual ﬁnger rather than individual residue level. Also,
our approach implicitly includes energetic contributions of
residues that are not directly involved in base contacts
(e.g. phosphate contacts), as well as energetic contribu-
tions resulting from context-dependent eﬀects that pre-
sumably occur among recognition helix residues within
each ﬁnger.
The apparent simplicity of modular assembly has
contributed to the current focus on C2H2 ZFDs as the
domains of choice for designing custom DNA binding
proteins. Our results make it possible, for the ﬁrst time,
to reliably identify prospective binding sites that are unli-
kely to yield functional ZFDs by modular assembly
using a set of GNN-speciﬁc ﬁnger modules. The rule-
based strategy presented here can provide accurate
guidance for both in vitro binding aﬃnities and in vivo
functionality for engineered ZFPs by computing energy
contributions of individual ZFDs. We have updated the
Zinc Finger Targeter (ZiFiT) web server (http://bindr.gd
cb.iastate.edu/ZiFiT) (48) so that it now provides users
with a list of potential ZFP-target site pairs for a desired
genomic sequence, scored according to the procedures
developed and validated in this work.
SUPPLEMENTARY DATA
Supplementary Data are available at NAR Online.
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